April 25, 2012
Ono Pharmaceutical announced on April 23 that it has upwardly revised its consolidated financial forecast for the fiscal year ended March 2012. Operating, ordinary, and net profits have been upwardly revised because SG&A expenses were less than expected and expenses...read more